Back

Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis Imaging ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

5 More presentations in this session

Presentation thumbnail
Genetic status and response patterns to mavacamten: an echocardiographic signature of reverse remodeling from 3 portuguese centers
Doctor I. Miranda (Amadora, PT)
Abstract
Presentation thumbnail
Musculoskeletal events and risk of amyloidosis in the general population
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Abstract
Presentation thumbnail
Circulating transthyretin as an independent systemic vulnerability signal in transthyretin amyloidosis: insights from the French HEAR Registry
Assistant Professor A. Zaroui (Creteil, FR)
Abstract
Presentation thumbnail
Changes over time in AI-based echocardiographic metrics before and after therapy in ATTR cardiomyopathy
Ms A. Walser (Zurich, CH)
Abstract
Presentation thumbnail
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: the HCM-LGE risk score
1 September 2025
thumbnail
Congress Presentation
Predictors of left ventricular dysfunction in hypertrophic cardiomyopathy: results from a nationwide registry
27 August 2022
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.
28 August 2023
thumbnail
Congress Presentation
Prognostic assessment following acute myocarditis requires convalescent scanning: neither peak troponin nor index scan T2 signal predicts convalescent late gadolinium enhancement
6 May 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources